Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Military Medicine|February 17, 2009
Phase I study of a topical skin protectant against chemical warfare agentsArik Eisenkraft, Amir Krivoy, Aviv Vidan, et al.
Plos One|November 19, 2011
Mutagen-specific mutation signature determines global microRNA bindingEyal Greenberg, Gideon Rechavi, Ninette Amariglio, et al.
JAMA Network Open|October 23, 2020
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint InhibitorsDavid Bomze, Nethanel Asher, Omar Hasan Ali, et al.
Clinical Cardiology|June 5, 2014
Primary malignancies of the heart and pericardiumIvana Burazor, Sarit Aviel-Ronen, Massimo Imazio, et al.
The American Journal of Cardiology|June 1, 2011
Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndromeMassimo Imazio, Antonio Brucato, Gal Markel, et al.
Scientific Reports|January 13, 2021
Ocular side effects of novel anti-cancer biological therapiesVicktoria Vishnevskia-Dai, Lihi Rozner, Raanan Berger, et al.
Plos One|June 30, 2010
The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensisGal Markel, Erez Bar-Haim, Eran Zahavy, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 4, 2010
Triage and management of pericardial effusionMassimo Imazio, Bongani M Mayosi, Antonio Brucato, et al.
Clinical & Developmental Immunology|July 11, 2012
Novel anti-melanoma immunotherapies: disarming tumor escape mechanismsSivan Sapoznik, Ohad Hammer, Rona Ortenberg, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Military Medicine|February 17, 2009
Phase I study of a topical skin protectant against chemical warfare agentsArik Eisenkraft, Amir Krivoy, Aviv Vidan, et al.
Plos One|November 19, 2011
Mutagen-specific mutation signature determines global microRNA bindingEyal Greenberg, Gideon Rechavi, Ninette Amariglio, et al.
JAMA Network Open|October 23, 2020
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint InhibitorsDavid Bomze, Nethanel Asher, Omar Hasan Ali, et al.
Clinical Cardiology|June 5, 2014
Primary malignancies of the heart and pericardiumIvana Burazor, Sarit Aviel-Ronen, Massimo Imazio, et al.
The American Journal of Cardiology|June 1, 2011
Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndromeMassimo Imazio, Antonio Brucato, Gal Markel, et al.
Scientific Reports|January 13, 2021
Ocular side effects of novel anti-cancer biological therapiesVicktoria Vishnevskia-Dai, Lihi Rozner, Raanan Berger, et al.
Plos One|June 30, 2010
The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensisGal Markel, Erez Bar-Haim, Eran Zahavy, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 4, 2010
Triage and management of pericardial effusionMassimo Imazio, Bongani M Mayosi, Antonio Brucato, et al.
Clinical & Developmental Immunology|July 11, 2012
Novel anti-melanoma immunotherapies: disarming tumor escape mechanismsSivan Sapoznik, Ohad Hammer, Rona Ortenberg, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Pageof 14